Reuters - Experts clashed over the safety of Merck
& Co and Schering-Plough’s cholesterol drug Vytorin on Tuesday
as full results from a controversial study were presented at
Europe’s biggest medical congress.
Independent honest reviews of most effective natural herbal supplements
Reuters - Experts clashed over the safety of Merck
& Co and Schering-Plough’s cholesterol drug Vytorin on Tuesday
as full results from a controversial study were presented at
Europe’s biggest medical congress.
The URI to TrackBack this entry is: http://herbal-review.com/2008/09/02/heart-experts-clash-on-vytorin-and-cancer-risk-reuters/trackback/
Please healthy :)
You must be logged in to post a comment.
|No results yet!
23 queries. 1.044 seconds